PANION & BF BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.7 TWD | +0.93% |
|
+1.77% | -12.77% |
| 24/05 | Panion & Bf Biotech Inc. Announces the Cash Dividend, Payable on July 10, 2024 | CI |
| 13/05 | Panion & Bf Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Panion & Bf Biotech Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 32 M€ | +4.30% | - |
PANION & BF BIOTECH INC. is a Taiwan-based company principally engaged in the manufacture and sales of western medicines and experimental drugs. The Company is also involved in the manufacture and sales of various kinds of cosmetics. The Company's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The Company also provides biotechnology services. The Company distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.
Sector
Pharmaceuticals
Calendar
09/08/2024
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
97.7
TWD
Average target price
96
TWD
Spread / Average Target
-1.74%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.77% | 258M | |
| +45.82% | 765B | |
| +40.95% | 632B | |
| -6.16% | 354B | |
| +19.86% | 331B | |
| +9.32% | 299B | |
| +18.45% | 248B | |
| -0.78% | 219B | |
| +11.88% | 216B | |
| +5.90% | 164B |
- Stock Market
- Equities
- 1760 Stock
- Funds and ETFs Panion & Bf Biotech Inc.
